Back to Search
Start Over
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- Source :
- Nature medicine. 27(2)
- Publication Year :
- 2020
-
Abstract
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus Disease 2019 (COVID-19), has caused a global pandemic, and safe, effective vaccines are urgently needed
- Subjects :
- CD4-Positive T-Lymphocytes
Male
Immunity, Cellular
COVID-19 Vaccines
Adolescent
SARS-CoV-2
T-Lymphocytes
Vaccination
Dose-Response Relationship, Immunologic
COVID-19
CD8-Positive T-Lymphocytes
Middle Aged
Lymphocyte Activation
Immunity, Humoral
Immunoglobulin A
Interferon-gamma
Protein Subunits
Young Adult
Immunoglobulin M
ChAdOx1 nCoV-19
Antibody Formation
Spike Glycoprotein, Coronavirus
Humans
Female
Subjects
Details
- ISSN :
- 1546170X
- Volume :
- 27
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Nature medicine
- Accession number :
- edsair.pmid..........e447b1915b909bc9a4b340ef04f4dd4f